TNF and age-related macular degeneration: In clinical practice, intravitreal injection of steroids or antibody against tumor necrosis factor alpha (TNF-α), a key microglial inflammatory mediator, is effective in AMD patients (Theodossiadis et al., 2009; Becerra et al., 2011).